Last reviewed · How we verify
Urea Cream 20%
At a glance
| Generic name | Urea Cream 20% |
|---|---|
| Also known as | Urea group |
| Sponsor | Korea University Guro Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose) (NA)
- Development and Validation of an Investigator Global Assessment Score for Keratosis Pilaris
- A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier (PHASE2)
- Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia (PHASE2, PHASE3)
- The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction (PHASE4)
- Creams With or Without Urea Influence the Hydration of the Skin of the Foot (NA)
- FS2 Safety and Tolerability Study in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Urea Cream 20% CI brief — competitive landscape report
- Urea Cream 20% updates RSS · CI watch RSS
- Korea University Guro Hospital portfolio CI